AI-Enforced Ultra-Large Virtual Screening Discovers Potent CD28 Binders
Journal of Chemical Information and Modeling · 2026
DOI: 10.1021/acs.jcim.6c00859 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, 2026. Verfasst von Saurabh Upadhyay und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine, New York, New York10065, United States. Hauptthemen laut MEDLINE: CD28 Antigens, Small Molecule Libraries, Machine Learning. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Associazione Italiana per la Ricerca sul Cancro, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Targeting protein–protein interactions (PPIs) with small molecules is historically challenging due to shallow, solvent-exposed interfaces that lack classical binding pockets. Furthermore, employing traditional structure-based virtual screening (SBVS) across ultralarge chemical spaces to find novel chemotypes imposes prohibitive computational bottlenecks. Here, we report the first prospective, real-world application of the PyRMD2Dock platform, an AI-enforced SBVS workflow that integrates machine learning and standard docking available within the PyRMD Studio suite. To target the structurally demanding immune receptor CD28, a chemically diverse subset of 2.4 million molecules from the Enamine REAL Diversity Space was docked into a cleft adjacent to the canonical ligand interface. These data were used to train 672 classification models, and the optimized model rapidly screened the remaining ∼46 million compounds. Following interaction filtering and clustering, 232 highly prioritized ligands were identified. Experimental validation of 150 purchased candidates yielded a strong hit rate, identifying multiple direct CD28 binders. Lead compounds 100 and 104 exhibited submicromolar affinity (Kd = 343.8 nM and 407.1 nM, respectively), potent CD28-CD80 disruption, and functional blockade in cellular reporter assays. Furthermore, these compounds successfully reduced cytokine secretion in primary human tumor-PBMC and epithelial tissue coculture models. This study validates PyRMD2Dock as a highly scalable, effective protocol for mining massive chemical libraries to discover small-molecule modulators of challenging immune receptor interfaces.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine, New York, New York10065, United States.
- DiSTABiF, University of Campania Luigi Vanvitelli, 81100Caserta, Italy.
ORCID-Profile: Saurabh Upadhyay, Michele Roggia, Sandro Cosconati, Moustafa T Gabr
Förderung
- NIDDK NIH HHS
- Associazione Italiana per la Ricerca sul Cancro
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Upadhyay, S., Roggia, M., Yuan, S., Cosconati, S., & Gabr, M. T. (2026). AI-Enforced Ultra-Large Virtual Screening Discovers Potent CD28 Binders. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.6c00859
Vancouver
Upadhyay S, Roggia M, Yuan S, Cosconati S, Gabr MT. AI-Enforced Ultra-Large Virtual Screening Discovers Potent CD28 Binders. Journal of Chemical Information and Modeling. 2026. doi:10.1021/acs.jcim.6c00859
BibTeX
@article{Upadhyay2026,
author = {Upadhyay, Saurabh and Roggia, Michele and Yuan, Shaoren and Cosconati, Sandro and Gabr, Moustafa T},
title = {AI-Enforced Ultra-Large Virtual Screening Discovers Potent CD28 Binders},
journal = {Journal of Chemical Information and Modeling},
year = {2026},
doi = {10.1021/acs.jcim.6c00859}
}
EUVIMED